Low sulfated glycosaminoglycans are excreted in patients with the Lowe syndrome.
Glycosaminoglycans (GAGs) were prepared from the urine of three patients and from normal individuals by cetylpyridinium chloride precipitation and Pronase digestion. The GAGs were analyzed by electrophoresis, anion-exchange chromatography, and enzymatic and chemical degradation. Each of the three patients showed a four- to fivefold increase in urinary GAG excretion compared to normal controls and in one patient a tenfold increase was measured during a period of behavioral agitation which included joint swelling. Urinary GAGs from affected individuals were characterized by a high proportion of low sulfated molecules. The predominant low sulfated component was chondroitin-4-sulfate (C4S); however, small amounts of chondroitin-6-sulfate (C6S) were also present. Heparan sulfate (HS) was present in normal proportion (5-10%) and most of it was not low sulfated. Abnormal excretion of chondroitin (Ch), hyaluronic acid (HA), and dermatan sulfate (DS) was not detected. These findings suggest that the clinical manifestations of Lowe syndrome may be caused by a defect in GAG metabolism.
D000293:Adolescent; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D002809:Chondroitin Sulfates / Q000652:urine; D002852:Chromatography, Ion Exchange; D004187:Disaccharides / Q000652:urine; D004588:Electrophoresis, Cellulose Acetate; D006025:Glycosaminoglycans / Q000652:urine*; D006801:Humans; D009800:Oculocerebrorenal Syndrome / Q000652:urine*; D015499:Renal Tubular Transport, Inborn Errors / Q000652:urine*
D004187:Disaccharides; D006025:Glycosaminoglycans; D002809:Chondroitin Sulfates